ConductScience.org, home

Paper9155696

A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.

Thomas MD and 8 others. J Clin Pathol, 1997. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status. Papers, record 9155696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9155696

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
PubMed
Journal
J Clin Pathol
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2019-05-01
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thomas MDM D
2McIntosh GGG G
3Anderson JJJ J
4McKenna DMD M
5Parr AHA H
6Johnstone RR
7Lennard TWT W
8Horne CHC H
9Angus BB

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antibody SpecificityMajor topic
Enzyme-Linked Immunosorbent AssayMajor topic
Tumor Suppressor Protein p53Major topic
Blotting, Western
Breast Neoplasms
Female
Humans
Immunohistochemistry

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12428616Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.Eur J Biochem1986https://conductscience.org/library/papers/2428616PubMed
22531845Mutations in the p53 gene occur in diverse human tumour types.Nature1989https://conductscience.org/library/papers/2531845PubMed
31905840p53 mutations in human cancers.Science1991https://conductscience.org/library/papers/1905840PubMed
41679056Nuclear p53 immunoreaction associated with poor prognosis of breast cancer.Jpn J Cancer Res1991https://conductscience.org/library/papers/1679056PubMed
51376364Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library.J Mol Biol1992https://conductscience.org/library/papers/1376364PubMed
68554979p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry.Br J Cancer1996https://conductscience.org/library/papers/8554979PubMed
78502476Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.Oncogene1993https://conductscience.org/library/papers/8502476PubMed
87685617Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.Br J Cancer1993https://conductscience.org/library/papers/7685617PubMed
98251647Prognostic significance of p53 gene alterations in node-negative breast cancer.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8251647PubMed
107524772Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7524772PubMed
117537340Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.J Mol Biol1995https://conductscience.org/library/papers/7537340PubMed
121614522Cancer. p53, guardian of the genome.Nature1992https://conductscience.org/library/papers/1614522PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
34361728Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based Derivatives.Molecules2021https://conductscience.org/library/papers/34361728PubMed
33790542Nα-1, 3-Benzenedicarbonyl-Bis-(Amino Acid) and Dipeptide Candidates: Synthesis, Cytotoxic, Antimicrobial and Molecular Docking Investigation.Drug Des Devel Ther2021https://conductscience.org/library/papers/33790542PubMed
33530345Comparison of Metal Nanoparticles (Au, Ag, Eu, Cd) Used for Immunoanalysis Using LA-ICP-MS Detection.Molecules2021https://conductscience.org/library/papers/33530345PubMed
31286782In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N1,N3-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide.J Enzyme Inhib Med Chem2019https://conductscience.org/library/papers/31286782PubMed
21976978SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor.Int J Nanomedicine2011https://conductscience.org/library/papers/21976978PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9155696

GET https://conductscience.org/api/papers/v1/9155696/authors